Free access to lifesaving COVID treatment is ending. Hereâ€™s what to know
-----
UPDATE: Pfizer to charge $1,390 for its lifesaving Paxlovid COVID treatment on commercial marketThe federal government has announced the end date for free access to a COVID-19 treatment that significantly reduces hospitalization and the risk of death.
The Department of Health and Human Services revealed plans on Friday to shift Paxlovid to the commercial market by November, with Dec. 15 as the final date for providing coverage to insured individuals. Under the agreement with
